1
项与 EBV-Tscm Cytotoxic T Cells(University Hospital, Basel) 相关的临床试验Epstein-Barr Virus (EBV) -Specific T Memory Stem Cell (Tscm) Therapy to Treat EBV- Driven Lymphomas/ Diseases
In this multi-center open-label, non-randomized phase I/II intervention study three consecutive doses of donor-derived EBV Tscm-CTLs will be administered to 10 patients with treatment-refractory EBV lymphoma, diseases or PTLDs. EBV Tscm-CTLs will derive from hematopoietic cell transplant (HCT) or third-party donors.
100 项与 EBV-Tscm Cytotoxic T Cells(University Hospital, Basel) 相关的临床结果
100 项与 EBV-Tscm Cytotoxic T Cells(University Hospital, Basel) 相关的转化医学
100 项与 EBV-Tscm Cytotoxic T Cells(University Hospital, Basel) 相关的专利(医药)
100 项与 EBV-Tscm Cytotoxic T Cells(University Hospital, Basel) 相关的药物交易